Transcriptomic Biomarkers for Individual Risk Assessment in New-Onset Heart Failure

Circulation - United States
doi 10.1161/circulationaha.107.756544
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

An Uncommon Cause of New-Onset Heart Failure

Mayo Clinic Proceedings
Medicine
2017English

Biomarkers in Cardiovascular Disease: Statistical Assessment and Section on Key Novel Heart Failure Biomarkers

Trends in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2017English

Molecular Biomarkers for Diagnostics, Risk Stratification and Prediction of Chronic Heart Failure

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2016English

Biomarkers and Low Risk in Heart Failure. Data From COACH and TRIUMPH

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2015English

Biomarkers in Heart Failure and Associated Diseases

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

Predictors of 90-Days Readmissions for New Onset Heart Failure After Acute Coronary Syndrome

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Late‐onset Heart Failure After Treatment for Breast Cancer

Cancer
Cancer ResearchOncology
2019English

Utilizing Risk Readmission Assessment Tool for Nonhospice Palliative Care Consults in Heart Failure Patients

Journal of Palliative Medicine
MedicineAnesthesiologyPain MedicineNursing
2016English

Clinical Adoption of Prognostic Biomarkers: The Case for Heart Failure

Progress in Cardiovascular Diseases
Cardiovascular MedicineCardiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy